Attitudes and practices of pediatric oncologists regarding methadone use in the treatment of cancer-related pain

Results of a north American survey

Michael Roth, Dawn Davies, Sarah Friebert, Dan Wang, Mimi Kim, Shayna Zelcer

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Methadone is effective in the treatment of cancer-related pain in adults. Pediatric oncologists may be reluctant to use methadone, given the paucity of existing research and a lack of familiarity with its use. This study's purpose was to assess pediatric oncologists' experience, comfort and practice of methadone prescription, and determine interest in and appropriate venues for education on methadone. A 22-item survey was sent by electronic mail to 1912 practicing pediatric oncologists. Six hundred thirty-one pediatric oncologists (33%) responded to the survey. Seventy-two percent of respondents reported they prescribe methadone to <10% of their patients receiving opioids. Physicians practicing ≥10 years (84% vs. 76%, P=0.01), at centers that see ≥100 new patients per year (86% vs. 76%, P=0.003), or who have received prior education on methadone (89% vs. 54%, P<0.001) were more likely to have prescribed methadone. The primary reasons respondents did not utilize methadone included a lack of knowledge of methadone's pharmacodynamics (39%), effectiveness (39%), and/or dosing equivalence (34%). Perceived competence with dose equivalence, belief that methadone is effective, and working in a division where >20 patients per year died were all independently associated with having prescribed methadone to >10% of patients on opioids. Eighty-five percent of respondents would like additional education on methadone. Many pediatric oncologists lack experience and education in the use of methadone. Formal education initiatives should be implemented to enhance pediatric oncologists' comfort and expertise in methadone use.

Original languageEnglish (US)
Pages (from-to)103-107
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume35
Issue number2
DOIs
StatePublished - Mar 2013

Fingerprint

Methadone
Pediatrics
Education
Therapeutics
Cancer Pain
Surveys and Questionnaires
Oncologists
Opioid Analgesics
Prescriptions

Keywords

  • methadone
  • pain
  • pediatric oncology
  • pediatric palliative care

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Attitudes and practices of pediatric oncologists regarding methadone use in the treatment of cancer-related pain : Results of a north American survey. / Roth, Michael; Davies, Dawn; Friebert, Sarah; Wang, Dan; Kim, Mimi; Zelcer, Shayna.

In: Journal of Pediatric Hematology/Oncology, Vol. 35, No. 2, 03.2013, p. 103-107.

Research output: Contribution to journalArticle

@article{5f95db671c184a0b9edbfdeeb1023a2d,
title = "Attitudes and practices of pediatric oncologists regarding methadone use in the treatment of cancer-related pain: Results of a north American survey",
abstract = "Methadone is effective in the treatment of cancer-related pain in adults. Pediatric oncologists may be reluctant to use methadone, given the paucity of existing research and a lack of familiarity with its use. This study's purpose was to assess pediatric oncologists' experience, comfort and practice of methadone prescription, and determine interest in and appropriate venues for education on methadone. A 22-item survey was sent by electronic mail to 1912 practicing pediatric oncologists. Six hundred thirty-one pediatric oncologists (33{\%}) responded to the survey. Seventy-two percent of respondents reported they prescribe methadone to <10{\%} of their patients receiving opioids. Physicians practicing ≥10 years (84{\%} vs. 76{\%}, P=0.01), at centers that see ≥100 new patients per year (86{\%} vs. 76{\%}, P=0.003), or who have received prior education on methadone (89{\%} vs. 54{\%}, P<0.001) were more likely to have prescribed methadone. The primary reasons respondents did not utilize methadone included a lack of knowledge of methadone's pharmacodynamics (39{\%}), effectiveness (39{\%}), and/or dosing equivalence (34{\%}). Perceived competence with dose equivalence, belief that methadone is effective, and working in a division where >20 patients per year died were all independently associated with having prescribed methadone to >10{\%} of patients on opioids. Eighty-five percent of respondents would like additional education on methadone. Many pediatric oncologists lack experience and education in the use of methadone. Formal education initiatives should be implemented to enhance pediatric oncologists' comfort and expertise in methadone use.",
keywords = "methadone, pain, pediatric oncology, pediatric palliative care",
author = "Michael Roth and Dawn Davies and Sarah Friebert and Dan Wang and Mimi Kim and Shayna Zelcer",
year = "2013",
month = "3",
doi = "10.1097/MPH.0b013e318279e492",
language = "English (US)",
volume = "35",
pages = "103--107",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Attitudes and practices of pediatric oncologists regarding methadone use in the treatment of cancer-related pain

T2 - Results of a north American survey

AU - Roth, Michael

AU - Davies, Dawn

AU - Friebert, Sarah

AU - Wang, Dan

AU - Kim, Mimi

AU - Zelcer, Shayna

PY - 2013/3

Y1 - 2013/3

N2 - Methadone is effective in the treatment of cancer-related pain in adults. Pediatric oncologists may be reluctant to use methadone, given the paucity of existing research and a lack of familiarity with its use. This study's purpose was to assess pediatric oncologists' experience, comfort and practice of methadone prescription, and determine interest in and appropriate venues for education on methadone. A 22-item survey was sent by electronic mail to 1912 practicing pediatric oncologists. Six hundred thirty-one pediatric oncologists (33%) responded to the survey. Seventy-two percent of respondents reported they prescribe methadone to <10% of their patients receiving opioids. Physicians practicing ≥10 years (84% vs. 76%, P=0.01), at centers that see ≥100 new patients per year (86% vs. 76%, P=0.003), or who have received prior education on methadone (89% vs. 54%, P<0.001) were more likely to have prescribed methadone. The primary reasons respondents did not utilize methadone included a lack of knowledge of methadone's pharmacodynamics (39%), effectiveness (39%), and/or dosing equivalence (34%). Perceived competence with dose equivalence, belief that methadone is effective, and working in a division where >20 patients per year died were all independently associated with having prescribed methadone to >10% of patients on opioids. Eighty-five percent of respondents would like additional education on methadone. Many pediatric oncologists lack experience and education in the use of methadone. Formal education initiatives should be implemented to enhance pediatric oncologists' comfort and expertise in methadone use.

AB - Methadone is effective in the treatment of cancer-related pain in adults. Pediatric oncologists may be reluctant to use methadone, given the paucity of existing research and a lack of familiarity with its use. This study's purpose was to assess pediatric oncologists' experience, comfort and practice of methadone prescription, and determine interest in and appropriate venues for education on methadone. A 22-item survey was sent by electronic mail to 1912 practicing pediatric oncologists. Six hundred thirty-one pediatric oncologists (33%) responded to the survey. Seventy-two percent of respondents reported they prescribe methadone to <10% of their patients receiving opioids. Physicians practicing ≥10 years (84% vs. 76%, P=0.01), at centers that see ≥100 new patients per year (86% vs. 76%, P=0.003), or who have received prior education on methadone (89% vs. 54%, P<0.001) were more likely to have prescribed methadone. The primary reasons respondents did not utilize methadone included a lack of knowledge of methadone's pharmacodynamics (39%), effectiveness (39%), and/or dosing equivalence (34%). Perceived competence with dose equivalence, belief that methadone is effective, and working in a division where >20 patients per year died were all independently associated with having prescribed methadone to >10% of patients on opioids. Eighty-five percent of respondents would like additional education on methadone. Many pediatric oncologists lack experience and education in the use of methadone. Formal education initiatives should be implemented to enhance pediatric oncologists' comfort and expertise in methadone use.

KW - methadone

KW - pain

KW - pediatric oncology

KW - pediatric palliative care

UR - http://www.scopus.com/inward/record.url?scp=84874482007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874482007&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e318279e492

DO - 10.1097/MPH.0b013e318279e492

M3 - Article

VL - 35

SP - 103

EP - 107

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 2

ER -